Scleroderma Newsroom
ISN News Manager: Jo Frowde
Media Stories
Autoimmune Archive
2015: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2017 - 2016 - 2015 - 2014

February 2015 Autoimmune News

Vitamin D and systemic lupus erythematosus (SLE): continued evolution. This reviews the recent literature regarding vitamin D and SLE, as well as current recommendations for vitamin D supplementation in patients with SLE. PubMed, Int J Rheum Dis, 2014 Dec 19. (Also see Research on Systemic Lupus Erythematosus)

Evidence of ERBB3 gene association with rheumatoid arthritis (RA) predisposition. This study correlates ERBB3 gene with RA susceptibility, adding to a previous report of chromosome 12q13 association with RA liability. PubMed, Int J Rheum Dis, 2014 Dec 20. (Also see Causes of Rheumatoid Arthritis)

Diabetes mellitus (DM) risk factors in rheumatoid arthritis (RA): a systematic review and meta-analysis. RA is associated with increased risk of DM, including T1DM and T2DM. PubMed, Clin Exp Rheumatol, 2014 Dec 22. (Also see Rheumatoid Arthritis in Overlap and Symptoms and Complications of Diabetes)

Rheumatoid vasculitis: an update. Rheumatoid vasculitis remains a rare yet challenging extra-articular manifestation of rheumatoid arthritis with high morbidity and mortality, despite aggressive use of disease-modifying therapy. PubMed, Curr Opin Rheumatol, 2015 Jan;27(1):63-70. (Also see Symptoms and Complications of Rheumatoid Arthritis and Vasculitis)

Placebo-induced decrease in fatigue: evidence for a central action on the preparatory phase of movement. This placebo-induced modulation suggests that placebos reduce fatigue by acting centrally during the anticipatory phase of movement, thus emphasizing the important role of the central nervous system in the generation of fatigue. PubMed, Eur J Neurosci, 12/19/2014. (Also see Fatigue)

Predictors for health improvement in patients with fibromyalgia (FM): a 2-year follow-up study. Recently diagnosed FM patients who report fewer physical limitations may experience more improvement in health if they are at work and have a positive attitude towards participating in an offered health-care intervention. PubMed, Clin Rheumatol, 2015 Jan;34(1):133-41. (Also see Treatments for Fibromyalgia)

High fidelity between saliva proteomics and the salivary glands' biological state defines biomarker-signatures for primary Sjögren's syndrome (SS). The SS-related molecular landscape conveyed by saliva showed great congruence with histopathology features evoked by SS and advances understanding of this disease at a molecular level. PubMed, Arthritis Rheumatol, 12/29/2014. (Also see Diagnosis of Sjogren's Syndrome)

The Overlap and Distinction of Self-Reported Symptoms between Interstitial Cystitis/Bladder Pain Syndrome and Overactive Bladder: A Questionnaire Based Analysis. There is considerable overlap of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder. PubMed, J Urol, 2014 Dec;192(6):1679-86. (Also see Interstitial Cystitis)

Coffee or tea consumption and the risk of rheumatoid arthritis (RA): a meta-analysis. High coffee consumption is associated with an elevated risk of RA development. The association between coffee and RA was found in seropositive RA, but not in seronegative RA. PubMed, Clin Rheumatol, 2014 Nov;33(11):1575-83. (Also see Causes of Rheumatoid Arthritis)

Blood Test Could Prevent Medication Trial and Error for Rheumatoid Arthritis Patients. A molecule in the blood shows promise as a marker to predict whether individual rheumatoid arthritis patients are likely to benefit from biologic medications or other drugs should be tried. PubMed, Mayo Clinic News Network, 11/17/2014. (Also see Treatments for Rheumatoid Arthritis)

Go to Autoimmune News: January 2015

United Way of Central New Mexico
United Way of Snohomish County
See ISN News for recent donors, including Juliet Youkhana; and donations in loving memory of Jim Miller and Arlene Marie Petulla.
Click Here to Donate or Shop
or click on the floating green DONATE button.


TOLL FREE HOTLINE, U.S. and Canada: 1-800-564-7099
Ask for our Free Info Packet by email or postal mail!

SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email [email protected] to request our Welcome email, or to report bad links or to update this page content. Privacy Policy.

The most important thing in the world to know about scleroderma is!

Donate Now
Copyright 1998-2017, International Scleroderma Network. AKA Scleroderma from A to Z and SCLERO.ORG. All Rights Reserved.